Ramm Pharma Corp.’s Acquisition Of 49% Interest in Canapar Corp.

Ramm Pharma investe in Canapar rilevandone il 49%
Ambrogio Visconti
Tagged:

Cassels Brock & Blackwell and Grimaldi Studio Legale have represented Ramm Pharma in the transaction. Ramm Pharma Corp., a leader in plant-derived cannabinoid (CBD) pharmaceutical and…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now